HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.
YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.
N/A
Parallel
Brief Videos for HIV Stigma
BehavioralIntersectionally-tailored brief videos to reduce public and internalized HIV stigma (BVHS)
Percentage of participants who attend an HIV care visit within 30 days after enrollment
Linkage to HIV care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Percentage of participants who are linked to HIV prevention within 30 days after enrollment
Linkage to HIV prevention is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
Percentage of participants who are linked to mental health care
Linkage to mental health care is defined as completion of at least one visit with a STRIVE telehealth navigator, within 30 days after enrollment. Visit attendance will be recorded as Yes or No documented by a STRIVE telehealth navigator. The outcome will be reported as the percentage of participants who meet this criterion.
brief Berger HIV Stigma scale
The 12-item Brief Berger HIV Stigma Scale is a shortened, validated version of the original 40-item Berger HIV Stigma Scale designed to measure perceived, anticipated, and internalized stigma among people living with HIV (PLWH) while reducing respondent burden. Cumulative scores range from 12 to 48, with higher scores reflecting higher levels of perceived stigma.
Attitudes Toward Seeking Professional Psychological Help Scale-Short Form
A 10-item questionnaire used to measure a person's general openness and perspective on getting mental health therapy. Total scores generally range from 0 to 30, with higher scores showing a more positive attitude toward going to therapy.
Patient Health Questionnaire-9
A 9-item self-administered tool used to screen, diagnose, monitor, and measure the severity of depression. Each of the 9 questions is scored from 0 (not at all) to 3 (nearly every day). Total Score Range: 0 to 27 .Score Interpretation 0-4: Minimal or no depression. 5-9: Mild depression. 10-14: Moderate depression. 15-19: Moderately severe depression. 20-27: Severe depression
Generalized Anxiety Disorder-7
A short, 7-question self-report questionnaire used to screen for generalized anxiety disorder and measure symptom severity. Each item is scored from 0 to 3: 0 = Not at all 1. = Several days 2. = More than half the days 3. = Nearly every day Total Score: 0-4: Minimal anxiety 5-9: Mild anxiety (monitor symptoms) 10-14: Moderate anxiety (possible clinically significant condition) 15-21: Severe anxiety (active treatment likely warranted
Posttraumatic stress disorder symptoms
8-item short-form version of the PTSD Checklist for DSM-5 (PCL-5), designed to measure post-traumatic stress disorder (PTSD) symptom severity.
HIV care provider visit
Single yes/no survey item, CHP clinic confirmation
Click on the lead sponsor to view all of their trials.
City University of New York, School of Public Health
Lead sponsor
Columbia University
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
